Tasman Oncology Research
Southport, Queensland, Australia
Cancer treatment center in Southport, Queensland
7/3/123 Nerang St, Southport QLD 4215
About Tasman Oncology Research
"Providing specialized cancer care treatments and clinical trials on the Gold Coast."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Tasman Oncology Research
During the past decade, Tasman Oncology Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on
average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
2008-10-01
2014-08-01
Completed
80
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
2009-08-01
2021-10-21
Completed
115
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
2010-02-01
2018-03-01
Terminated
313
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tasman Oncology Research" #1 sponsor was "Amgen" with 2 trials, followed by "BeiGene" with 2 trials
sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bayer"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tasman Oncology Research"
#1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Tasman Oncology Research
According to Clinical.Site data, the most researched conditions in "Tasman Oncology Research" are
"Melanoma" (2 trials), "Neoplasm Metastasis" (2 trials), "Solid Tumors" (2 trials), "Abiraterone Acetate" (1 trials) and "Adenoid Cystic Carcinoma" (1 trials). Many other conditions were trialed in "Tasman Oncology Research" in a lesser frequency.
Clinical Trials Intervention Types at Tasman Oncology Research
Most popular intervention types in "Tasman Oncology Research" are "Drug" (12 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (4 trials), "Nivolumab" (2 trials), "Abemaciclib" (1 trials), "Abiraterone" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tasman Oncology Research
The vast majority of trials in "Tasman Oncology Research" are
13 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Tasman Oncology Research
Currently, there are NaN active trials in "Tasman Oncology Research".
undefined are not yet recruiting,
3 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Tasman Oncology Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tasman Oncology Research, 7 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".